Coronavirus: Why this small cap ASX biotech share jumped 12% higher

The Zoono Group Ltd (ASX:ZNO) share price jumped 125 higher on Wednesday. Here's why the biotech share is benefiting from COVID-19…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price has been a strong performer on Wednesday.

The global biotech company's shares were up as much as 12% to $1.42 at one stage.

In late trade they have given back some of these gains, but are still up around 4% to $1.32.

Why did the Zoono share price rocket higher today?

Investors were buying the company's shares today after it announced that it has entered into an Exclusive Distribution Agreement with Al Rabban Capital for the distribution of Zoono products in the Middle East and North Africa.

Zoono's products include scientifically-validated, long-lasting, and environmentally-friendly antimicrobial solutions. These comprise sprays, wipes, and foams suited for skin care, surface sanitisers, and mould remediation treatments.

Al Rabban Capital is a leading provider of professional services with extensive networks, investments, and distribution channels in the MENA Region. It is based in Doha, Qatar.

According to the release, management believes the agreement with Al Rabban Capital demonstrates the international demand for Zoono's technology and its ability to be part of the solution against the spread of viruses and bacteria. This is particularly the case given the ongoing spread of coronavirus globally.

What are the terms?

The two parties have signed a five-year agreement with a right of renewal for a further five-years.

The deal gives Al Rabban Capital exclusive distribution rights to B2B and consumer retail markets in the Middle East and North Africa, with the exception of several smaller countries due to existing relationships.

There will be minimum annual purchases of NZ$4.8 million in the first 12 months, NZ$8 million in year two, NZ$12 million in year three, and then 10% per annum increases thereafter. The initial order lodged by Al Rabban Capital is for NZ$2.4 million.

Management also advised that the company does not have any supply issues for large quantities at this stage. Its production will be funded from its existing cash reserves and it has sufficient resources, including people, to supply Al Rabban in accordance with the agreement.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here's how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here's what Rio Tinto (ASX:RIO) boss says is 'causing some challenges' right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.
Economy

CBA reveals the Australian economy's leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »